
Geneva, July 28, 2025 (WHO) – in the commemoration of the World Hepatitis DayWHO calls governments and associates a call to accelerate efforts urgently to eliminate viral hepatitis as a threat to public health and reduce deaths by warming liver.
«Every 30 seconds, someone dies of severe liver cooling or liver cancer linked to hepatitis, although we have the means to curb cooling,» said Dr. Tedros Adhanom Ghebreyesus, CEO of WHO.
Viral hepatitis – types A, B, C, Dye – are important causes of acute liver infection. Hepatitis of these, only hepatitis B, C and D can cause chronic infections that increase the risk of cirrhosis, liver failure or liver cancer, but most people with hepatitis do not know that they are infected. TUPOS B, CYD affect more than 300 thousand people worldwide and cause more than 1.3 million deaths every year, main for liver cirrhosis and cancer.
Hepatitis D now classified as cancer
The International Cancer Research Center (CIIC) Classified recently hepatitis D as cancer cancer for human beingsSome that hepatitis by C. Hepatitis D, which only affects a person with hepatitis B, sesocia at a risk of liver cancer of -Dos to six times mayor that if only hepatitis B is had. This reclassification is constitutions a step is the era the writing. Sensitization, improvement of the detection and expansion of access to new treatments against hepatitis D.
«In 2024 the WHO published guidelines on tests and diagnosis of hepatitis B and D And actively follow the clinical assessment criteria of innovative treatments against hepatitis D, ”said Dr. Meg Doherty, new director of the Health Science Department in WHO.
The treatment with oral medications can cure hepatitis C within 2 to 3 months and inhibit effective the hepatitis B virus with a coming treatment. The therapeutic options against hepatitis D evolve unparalleled. However, the full benefit of reducing deaths due to liver cirrhosis and cancer can only be achieved with urgent measures to expand at scale and integrate services against hepatitis – in particular vaccination, tests, damage reduction and treatment – in national health systems.
Last data and advances
It is encouraging that most low and medium income countries have strategic plans on hepatitis and that advances in national responses to this disease are increasing:
- In 2025, the number of countries that named National Action Action plans against hepatitis increased from 59 to 123;
- Since 2025, 129 countries have adopted policies for hepatitis B detection tests among muddled women, compared to 106 of 2024; AND
- 147 countries have introucous the hepatitis B vaccine at birth, compared to 138 of 2022.
Embargo on sin, there are still important deficiencies in the coverage of services and in the outcomes, as indicated in the 2024 World Report on hepatitis:
- The coverage of tests and treatments remains low Crystice; Only 13 % of people with hepatitis B and 36 % of those who have hepatitis C breast diagnosis in 2022;
- Treatment rates were even lower (3 % for hepatitis B and 20 % for hepatitis c), very well under the goals by 2025, this, 60 % of diagnostic cases and 50 % treated;
- The integration of services against hepatitis remains unequal: 80 countries have incorporated services against hepatitis in primary health atance; 128 In HIV programs and only 27 have integrated services against hepatitis C in the Daros Reduced Centers.
The next challenge will be to expand the coverage of prevention, tests and treatment. Reaching the WHO goal by 2030 could save 2.8 thousand lives and prevent 9.8 thousand new infections. Given the reduction of donor support, countries must give priority to investment investment, the integunation of services, the improvement of the data, the affordability of medicines and the elimination of stigmatization.
Forge New Alianca
To commemorate World Hepatitis Day, WHO has been associated with Roty International and the World Hepatitis Alliance to strengthen world and local promotion. In this year’s campaign, with the motto «Hepatitis: let’s know her to fight her», The adoption of measures is required to deal with the cricket of liver cancer victims by chronic hepatitis. Decisive measures are also requested to dismantle persistent obstacles – from stigmatization to lack of financing – which continues to slow down the progress in prevention, evidence and treatment.
A Travans of a Web Seminar Coordinated set and dissemination activities, the alliance underlines the vital function of civil society and community leaders, as well as governments, parapulse and accelerate and accelerate programming towards the elimination of hepatitis.